Articles

Taking cues from launches so far in oncology and rheumatology, three important considerations for biosimilar marketability are outlined

Key learnings to support biosimilar commercialization in the US

Parties will collaborate in enhancing chronic disease care therapies

Eversana, Janssen sign RWD agreement

Deal expands pharma giant’s influence in inflammation and immunology markets

Pfizer purchases Arena Pharmaceuticals for $6.7 billion

The $17.4-billion deal, CDMO says, will help expand its offerings in the clinical development space

Thermo Fisher Scientific completes acquisition of PPD

Collaboration focuses on continuing to improve time to therapy and medication adherence for patients, while effectively optimizing clinical data

Surescripts and Diameter Health establish clinical intelligence partnership 

CDMO’s financial commitment will feature construction of a new GMP clinical trial development facility

CordenPharma to invest $10.9 million in oral solid drug manufacturing

Transaction is anticipated to further Novo’s research in the field of RNAi therapeutics

Novo Nordisk inks $3.3 billion deal for Dicerna Pharma

Four trends shaping healthcare in 2022 and beyond

What’s Next for Med Tech?

How AI-powered support automation can solve the data problem in clinical trial
management

Chatbot Potential in Clinical Research

Ongoing strides in data mining, data analytics, modeling and simulation are
opening up new and more definitive opportunities to apply data-driven insights
to improve everything from upstream drug discovery and clinical trials, to the
downstream go-to-market strategy and post-patent lifecycle management

Clinical Operations